AllianceBernstein’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-314,412
| Closed | -$47.5M | – | 3384 |
|
2022
Q3 | $47.5M | Sell |
314,412
-37,465
| -11% | -$5.66M | 0.02% | 546 |
|
2022
Q2 | $51.3M | Sell |
351,877
-291,459
| -45% | -$42.5M | 0.02% | 542 |
|
2022
Q1 | $76.3M | Sell |
643,336
-510,992
| -44% | -$60.6M | 0.03% | 484 |
|
2021
Q4 | $159M | Buy |
1,154,328
+78,494
| +7% | +$10.8M | 0.06% | 313 |
|
2021
Q3 | $149M | Sell |
1,075,834
-324,086
| -23% | -$45M | 0.06% | 307 |
|
2021
Q2 | $136M | Sell |
1,399,920
-56,639
| -4% | -$5.5M | 0.05% | 336 |
|
2021
Q1 | $99.6M | Buy |
1,456,559
+251,355
| +21% | +$17.2M | 0.04% | 403 |
|
2020
Q4 | $103M | Sell |
1,205,204
-243,960
| -17% | -$20.9M | 0.05% | 372 |
|
2020
Q3 | $94.2M | Buy |
1,449,164
+230,636
| +19% | +$15M | 0.05% | 342 |
|
2020
Q2 | $89.1M | Sell |
1,218,528
-297,282
| -20% | -$21.7M | 0.05% | 343 |
|
2020
Q1 | $51.6M | Sell |
1,515,810
-98,380
| -6% | -$3.35M | 0.04% | 434 |
|
2019
Q4 | $87.9M | Sell |
1,614,190
-296,991
| -16% | -$16.2M | 0.05% | 361 |
|
2019
Q3 | $79.7M | Buy |
1,911,181
+504,090
| +36% | +$21M | 0.05% | 370 |
|
2019
Q2 | $61.6M | Sell |
1,407,091
-56,018
| -4% | -$2.45M | 0.04% | 479 |
|
2019
Q1 | $75.3M | Buy |
1,463,109
+72,090
| +5% | +$3.71M | 0.05% | 392 |
|
2018
Q4 | $51.4M | Sell |
1,391,019
-193,963
| -12% | -$7.17M | 0.04% | 462 |
|
2018
Q3 | $59.5M | Sell |
1,584,982
-216,398
| -12% | -$8.13M | 0.04% | 456 |
|
2018
Q2 | $71.2M | Buy |
1,801,380
+343,353
| +24% | +$13.6M | 0.05% | 399 |
|
2018
Q1 | $37.6M | Sell |
1,458,027
-139,729
| -9% | -$3.6M | 0.03% | 573 |
|
2017
Q4 | $43.1M | Buy |
1,597,756
+733,526
| +85% | +$19.8M | 0.03% | 529 |
|
2017
Q3 | $32.3M | Buy |
864,230
+429,021
| +99% | +$16M | 0.02% | 614 |
|
2017
Q2 | $10.9M | Buy |
+435,209
| New | +$10.9M | 0.01% | 895 |
|